secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orthofix Medical Inc. (OFIX)
CIK:        0000884624
Form:       8-K
Filed at:   2023-08-08T23:59:59+00:00
Accession:  0000950170-23-039871
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orthofix Q2 2023 revenue $187M (+7% pro forma), raises FY adjusted EBITDA guidance
--------------------------------------------------------------------------------

- Net sales $187.0M, up 58% reported / 7% pro forma constant currency YoY.
- GAAP EPS $(1.07); adjusted EPS $0.02; adjusted EBITDA $9.9M (5.3% margin).
- Bone Growth Therapies grew 10.3% YoY; U.S. spine implants +7% pro forma.
- FY23 net sales guidance raised to $752-758M; adjusted EBITDA to $42-46M.
- Full commercial launch of WaveForm A interbody and TrueLok Phantom/Tornado hinges.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/884624/000095017023039871/0000950170-23-039871-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/884624/000095017023039871/ofix-20230808.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-039871

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer